The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
Verisign
VRSN · a US exchange · USD · Market cap $25.9B · 926 employees
VeriSign, Inc., together with its subsidiaries, provides internet infrastructure and domain name registry services that enables internet navigation for various recognized domain names worldwide.
FAIL · Does not pass the screenAt the last full screen
2026-09-09
Screened 2026-09-09 · the tape above runs as of 23:00 UTC · 20 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 286.94 against the desk's fair-value range, base estimate 281.39, over the last year.
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against today's price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Verisign holds its Markup at $286.94. The statistical read favours the buyers, held for 11 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 11 days |
| Price at the screen | $286.94 |
| Valuation | 31.19 trailing · 26.11 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.70 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 135.61% | Below 33% | Interest-bearing debt is 135.6% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 20.56% | Below 33% | Cash held in interest-bearing accounts and securities is 20.6% of assets, under the one-third limit. | Pass |
| Receivables | 23.80% | Below 49% | Money owed to the company is 23.8% of assets, under the 49% limit. | Pass |
| Revenue purity | 1.60% | Below 5% | Only 1.6% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades above our $281.39 fair value estimate, 6.00% revenue growth.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. The price runs 1.9% above the base estimate.
Third-party analyst targets: 5 covering, consensus Buy. The average target sits +13% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsVerisign Runs the Dot Com Backbone
Every time someone types a .com address the query hits Verisign's registry before anything else loads. The business sits on near fifty percent profit margins and steady seven percent revenue growth, yet the shares trade at two hundred seventy eight dollars against our fair value of two hundred fifty nine. We pass.
The forward multiple of twenty six point five times leaves no margin of safety. Analyst targets sit higher, but those forecasts ignore the simple fact that the price already exceeds what the cash flows justify today. High margins alone do not turn an expensive stock into a fair one.
The ethical screen fails on the debt ratio, a hard stop regardless of the numbers. Currency or cyclical traps are absent here, yet the combination of stretched valuation and leverage is enough to keep us away. Analysis, not advice.
| Forward P/E | 26.1xexpensive even after accounting for its growth |
| Trailing P/E | 31.2xa premium valuation |
| EPS, trailing | 9.20 |
| EPS, forward | 10.99 |
| Revenue growth | +6.0%slow but positive growth |
| Profit margin | 49.8%highly profitable on every dollar of sales |
| FCF yield | 3.21% |
| Dividend yield | 112.00% |
| Current ratio | 0.59below 1: short-term bills exceed liquid assets |
| Beta | 0.70steadier than the market |
| Short interest, float | 0.02% |
| 52-week range | 208.86 - 312.48 |
| Market cap | $25.9B |
| Employees | 926 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeVRSN trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 5%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- VeriSign Seen With Multiple Catalysts Into 2027, Wedbush Says MT Newswires · 19d ago
- Are Wall Street Analysts Bullish on VeriSign Stock? Barchart · 28d ago
- Zacks Industry Outlook Highlights Verisign and Donnelley Financial Zacks · 17 Aug 2026
- Software & Services: Buy Verisign, Hold Donnelley Financial Zacks · 14 Aug 2026
- VeriSign CEO James Bidzos Sells 3,300 Shares for $979,000 Motley Fool · 13 Aug 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-28 | MCPHERSON DANNY R | Officer | 5,000 | $1,355,106 | |
| 2026-04-14 | INDELICARTO THOMAS C | General Counsel | 498 | $134,490 | |
| 2026-04-07 | INDELICARTO THOMAS C | General Counsel | 498 | $136,452 | |
| 2026-03-25 | INDELICARTO THOMAS C | General Counsel | 498 | $124,500 | |
| 2026-03-10 | INDELICARTO THOMAS C | General Counsel | 332 | $79,886 | |
| 2026-03-03 | INDELICARTO THOMAS C | General Counsel | 498 | $115,426 | |
| 2026-02-27 | ARMSTRONG COURTNEY D. | Director | 22 | $4,912 | |
| 2026-02-10 | INDELICARTO THOMAS C | General Counsel | 166 | $36,394 | |
| 2026-02-05 | BIDZOS DEMETRIOS JAMES | Chief Executive Officer | 18,039 | · | |
| 2026-02-05 | INDELICARTO THOMAS C | General Counsel | 4,810 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2025-10-03 | Julie Johnson | Democrat | buy | 1K–15K |
| 2025-10-03 | Julie Johnson | Democrat | sell | 1K–15K |
| 2025-10-03 | Julie Johnson | Democrat | buy | 1K–15K |
| 2025-10-03 | Julie Johnson | Democrat | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $285.71 | +0.8% | $0.81 | $1,011 | +1.1% |
| 2 months | $259.09 | +11.2% | $0.81 | $1,115 | +11.5% |
| 3 months | $234.53 | +22.8% | $0.81 | $1,232 | +23.2% |
| 6 months | $242.52 | +18.8% | $1.62 | $1,195 | +19.5% |
| 1 year | $275.08 | +4.7% | $3.16 | $1,059 | +5.9% |
| 2 years | $177.44 | +62.4% | $3.93 | $1,646 | +64.6% |
| 3 years | $217.67 | +32.4% | $3.93 | $1,342 | +34.2% |
| 5 years | $217.70 | +32.3% | $3.93 | $1,341 | +34.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever VRSN does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.